(Q38172322)

30 August 2017

title

Rethinking the war on cancer. (English)

1 reference

30 August 2017

Douglas Hanahan

1

1 reference

30 August 2017

language of work or name

English

0 references

publication date

16 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

383

1 reference

30 August 2017

issue

9916

1 reference

30 August 2017

page(s)

558-563

1 reference

An appeal to world leaders: stop cancer now.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Addressing the growing international challenge of cancer: a multinational perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Economic burden of cancer across the European Union: a population-based cost analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Winning the war: science parkour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Raising the bar: the curative potential of human cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Nivolumab plus ipilimumab in advanced melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Mechanisms of acquired resistance to targeted cancer therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Cancer heterogeneity: implications for targeted therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Circumventing cancer drug resistance in the era of personalized medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Modes of resistance to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Combinatorial drug therapy for cancer in the post-genomic era.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Managing drug resistance in cancer: lessons from HIV therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Synthetic lethal approaches to breast cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Harnessing synthetic lethal interactions in anticancer drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

BIM, PUMA, and the achilles' heel of oncogene addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Accessories to the crime: functions of cells recruited to the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Cancer stem cells: in the line of fire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

Carcinoma-associated fibroblasts are a promising therapeutic target.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2962226-6

7 January 2021

10.1016/S0140-6736(13)62226-6

Identifiers

DOI

1 reference

release_7dnlcq5yd5d2lnzq6g4y5x5kli

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7dnlcq5yd5d2lnzq6g4y5x5kli

24 November 2022

mapped directly with Wikidata item

1 reference